GlassScriptPhysician profile
Sarah Kovarik
NPI 1285099374
$1,862.29
in general payments reported to CMS, 2019-2025
20 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $462 · 2023: $273 · 2024: $396 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $540.36 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $193.35 | 2022-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $176.22 | 2023-2025 | |
| Ucb, INC. | $174.25 | 2021-2025 | Bimzelx |
| Janssen Biotech, INC. | $167.37 | 2021-2024 | Simponi Aria, Simponi, Stelara |
| Pfizer INC. | $93.15 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.15 | 2023-2024 | Cyltezo |
| Galderma Laboratories, L.P. | $69.73 | 2024-2025 | Aklief, Nemluvio |
| Genzyme Corporation | $68.16 | 2022-2024 | |
| Leo Pharma INC. | $66.73 | 2023-2025 | Adbry |
| Lilly USA, LLC | $40.57 | 2023-2025 | Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $38.24 | 2024-2025 | |
| Organon LLC | $35.75 | 2025 | Vtama |
| Botanix Sb INC | $21.59 | 2025 | Sofdra |
| Amgen INC. | $21.08 | 2025 | Otezla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $18.31 | 2025 | Zoryve |
| Epi Health, LLC | $18.28 | 2022 | |
| Fresenius Kabi USA, LLC | $17.63 | 2023 | Idacio |
| E.R. Squibb & Sons, L.L.C. | $15.31 | 2025 | Sotyktu |
| Incyte Corporation | $15.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Kovarik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.